SCHEMBL12021085

SCHEMBL12021085

CNC(=N)C(CC(=O)O)c1ccc(OCc2cccc(Oc3ccccc3)c2)cc1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 19/20 0.63
▸ FFAR4 Q5NUL3 1/20 0.55
▸ ACACB O00763 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4802757 0.83 FFAR1 (0.66) FFAR1FFAR4
SCHEMBL4802750 0.83 FFAR1 (0.66) FFAR1FFAR4
SCHEMBL13140282 0.81 FFAR1 (0.72) FFAR1FFAR4ACACB
SCHEMBL13118297 0.81 FFAR1 (0.71) FFAR1FFAR4
SCHEMBL13118298 0.79 FFAR1 (0.69) FFAR1FFAR4
SCHEMBL13118306 0.79 FFAR1 (0.69) FFAR1FFAR4
SCHEMBL13118300 0.79 FFAR1 (0.66) FFAR1FFAR4
SCHEMBL14286119 0.78 RXRB (0.56) FFAR1
SCHEMBL1508532 0.78 FFAR1 (1.00) FFAR1
SCHEMBL13118268 0.77 FFAR1 (0.60) FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893582-B1 Compounds, their pharmaceutical compositions and their use in treating metabolic disorders AMGEN INC (US) 2011-12-14 — — EP disclosed
Send feedback